Jul 04, 2025
2:1
For every share held, investors received 2. The price per share adjusted from $1937.25 to $968.63.
The split itself did not change the total investment value.
Remus Pharmaceuticals Ltd. (NSE:REMUS) operates in the Pharmaceuticals: major industry.
Remus Pharmaceuticals Ltd. company overviewRemus Pharmaceuticals Ltd.'s most recent stock split was on July 4, 2025. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.
Remus Pharmaceuticals Ltd. (NSE:REMUS) has split its stock 2 times: a 4-for-1 split on June 6, 2024 and a 2-for-1 split on July 4, 2025.
Remus Pharmaceuticals Ltd. has split its stock 2 times. This history records 2 forward splits between June 6, 2024 and July 4, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Remus Pharmaceuticals Ltd.'s 2-for-1 split on July 4, 2025, every share became 2 shares.
Remus Pharmaceuticals Ltd. has not announced a new split in our records. Its most recent split was on July 4, 2025, 1 year ago. Companies announce splits in advance, and any new NSE:REMUS split will appear on this page.
Already premium?